Navigation Links
Targeted therapy prolongs life in patients with HER2-positive breast cancer
Date:12/11/2009

SAN ANTONIO Lapatinib plus trastuzumab are significantly better than lapatinib alone in extending the lives of breast cancer patients whose tumors are HER2-positive, according to Kimberly Blackwell, M.D., associate professor of medicine at Duke University Medical Center. Blackwell presented the findings today at the CTRC-AACR San Antonio Breast Cancer Symposium.

Blackwell says the combination targeted therapy gave patients more than a four-month survival advantage over those who took lapatinib alone. She says the findings may be the first step toward a chemotherapy-free future.

"This is the first time that a pair of targeted therapies has been shown to be superior to any intervention that paired a targeted therapy with a hormonal or chemotherapy based approach," she said.

The results stem from a large, Phase III clinical trial where investigators randomized 296 patients with metastatic breast cancer to receive either lapatinib (also known as Tykerb) alone or lapatinib plus trastuzumab (Herceptin) once a day. All participants had metastatic disease that had continued to spread even after treatments with several interventions that included trastuzumab plus chemotherapy.

Blackwell says trastuzumab binds to and blocks part of the HER2 growth factor that appears on the surface of some breast cancer cells while lapatinib binds to a second growth factor, EGFR, and part of HER2 that sits below the cell surface. "It's sort of a double whammy, disabling the HER2 protein in two places instead of one."

Women who enrolled in the single-agent arm of the study and whose cancer continued to spread after four weeks were allowed to cross over to the other arm of the study to continue on the combined approach.

Fifty-two percent of the women enrolled in the lapatinib-only arm of the study crossed over to the combination arm. The median overall survival following treatment with lapatinib plus trastuzumab was 60.7 weeks comp
'/>"/>

Contact: Michelle Gailiun
michelle.gailiun@duke.edu
919-724-5343
Duke University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty
2. Targeted breast ultrasound can reduce biopsies for women under 40
3. Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV
4. Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers
5. Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger
6. Senate Votes to Proceed - 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare
7. AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer
8. Targeted heat therapy offers new standard treatment option for soft tissue sarcoma
9. Narconon Launches Operation Medicine Cabinet in Georgia - Prescription Drugs Commonly Abused Targeted
10. Argonne, University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials
11. Argonne, University of Chicago scientists develop targeted cancer treatment using nanomaterials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Ticket Down is a reputable source for 2015 Cleveland ... hot during the 2014-15 NBA season and they delighted their fan ... score of 118-88. , For the Cavaliers, this is ... they lost to the San Antonio Spurs. Once Lebron James ... making it to the NBA finals increased tenfold. The team ...
(Date:5/27/2015)... “We are honored to receive this gift ... and vice president of clinical affairs for SSCHC. “The ... to provide comprehensive care to more individuals and improve ... clinical care and behavioral health services for Milwaukee’s vulnerable ... of whom took advantage of the clinic’s behavioral health ...
(Date:5/27/2015)... 27, 2015 Continuing its commitment to ... patients in the community, SmartPractice® donated $25,000 ... C. Lincoln). SmartPractice Vice President of Human Resources Meg ... a $25,000 check to Paulla Miller, Sherry Gage, Dr. ... & Research Center on April 30. The center is ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 In today's ... getting tighter, it can be challenging for doctors and ... cutting edge treatments. , Austin-based HealthTronics, Inc. ... minimally invasive, mobile medical therapies for clinically sophisticated applications. ... with the acquisition of Laser Ventures, Inc ., ...
(Date:5/27/2015)... The new http://www.carsonenergy.com includes ... should consider oil and gas investing, the substantial tax ... drilled, industry news, IRA investing, definitions and acronyms, info-graphics ... knowledge and experience is now in one central location, ... able to access 24 hours a day, 7 days ...
Breaking Medicine News(10 mins):Health News:Cavs NBA Finals Tickets: Ticket Down Slashes Ticket Prices on Cleveland Cavaliers 2015 NBA Finals Tickets at Quicken Loans Arena and Offers Valuable Promo Code 2Health News:Sixteenth Street Community Health Centers To Expand Primary Care and Behavioral Health Services Through $1 Million Grant From Aurora's Better Together Fund 2Health News:SmartPractice Donates $25,000 to HonorHealth Breast Health and Research Center 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:Carson Energy Launches Next Generation Investor Website 2
... Sept. 12 GSI Securitization,Inc. (Pink Sheets: GSIEF) ... "GSI is engaged in a,project with nine separate ... and funding for healthcare accounts receivable. This is ... for funding of receivables in the,$2-trillion+ healthcare market. ...
... If you,re one of the,millions of Texans who ... your handkerchief: Allergy researchers at Presbyterian Hospital of,Dallas say ... decades. "The unusually wet weather this summer means ... for lots of people," said Gary Gross, MD, an,allergist ...
... 2007) -- The University of South Floridas global health ... AIDS has been strengthened with a $1.36-million research training ... USF Health received the five-year grant Sept. 11 from ... training program focused on the biomedical, behavioral, cultural and ...
... Sept. 12 Navitas Cancer Rehabilitation Centers,of ... providing integrated and,comprehensive cancer rehabilitation services, is ... new center in Albuquerque, New Mexico. The ... New Mexico Oncology,Hematology Consultants, Ltd., (NMOHC) the ...
... aid children in crucial days after trauma, developers say ... now allows doctors to monitor blood flow through the ... death in children with head injuries. , Brain trauma ... States. Almost 475,000 children suffer brain injuries annually, according ...
... depends on the steady work of a vital gene that ... School cancer geneticists have found. Their research reveals an ... system, and opens novel strategies for targeting the gene, which ... , We have identified a new pathway that is essential ...
Cached Medicine News:Health News:Allergists at Presbyterian Hospital of Dallas Say This Year's Fall Allergy Season Could be Worst in Decades 2Health News:Global Health Project targets reducing AIDS among India's adolescents 2Health News:Navitas Opens New Cancer Rehabilitation Center in Albuquerque in Conjunction With New Mexico Cancer Centers 2Health News:Navitas Opens New Cancer Rehabilitation Center in Albuquerque in Conjunction With New Mexico Cancer Centers 3Health News:Imaging Software Helps Track, Treat Injured Brains 2Health News:Unique role for blood formation gene identified 2
(Date:5/27/2015)... -- Doctors from the Sheikh Zayed Institute for ... System are the first in the ... benign but painful bone tumor that commonly occurs in ... high-intensity focused ultrasound (MR-HIFU) method. Two patients, 16-year-old ... have been treated successfully in a research study aimed ...
(Date:5/27/2015)... 2015 Water Street Healthcare Partners ... health care industry, announced today that it has ... the world,s leading global health care companies. The partnership ... firm established in 2013 as a new way ... developing pharmaceutical products and medical devices. ...
(Date:5/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/9ffv95/2015_strategies ... "2015 Strategies in the European Coagulation Testing Market" ... comprehensive five-country report contains 500 pages, 120 tables, ... potential market entrants identify and evaluate business opportunities ... the next five years. The report ...
Breaking Medicine Technology:Children's National first in US to destroy bone tumors with incisionless surgery 2Children's National first in US to destroy bone tumors with incisionless surgery 3Children's National first in US to destroy bone tumors with incisionless surgery 4Water Street Announces Pharmaceutical Development Partnership with Global Health Care Company 2European Coagulation Testing Market Strategies 2015 2
... Mass., June 24 Pressure,BioSciences, Inc. (Nasdaq: ... today announced,that it has been awarded a ... (2R44GM079059-02) from the National Institutes of Health,(NIH). ... directed towards the,development and commercialization of novel, ...
... Program to Advance to the Clinic Within a Year; Studies ... Generate Milestone Payment to ... Inc. (Nasdaq: MITI ) and Nycomed today announced the ... MT203.,Micromet received $775,000 (500,000 euros) from Nycomed for the achievement,of ...
Cached Medicine Technology:Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery 2Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery 3Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery 4Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 2Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 3Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 4
... Oxygen Concentrator is a low decibel, low ... oxygen for prescriptions up to 5 liters ... running concentrator at <40 dBA, this unit ... Concentrators are also an economical and safe ...
... NewLife Intensity is AirSep's new high ... power special respiratory applications. This concentrator can ... NewLife Intensity can save on equipment needs ... ,Operating at 20 psig (138 kPa), with ...
... most economical line of stationary oxygen concentrators, ... oxygen in home, hospital, and clinical settings. ... daily use throughout the world, this low ... performance, easy maintenance, and unmatched reliability. (Flow ...
OCD-3000 pnuematic conserving regulator for large cylinder....
Medicine Products: